The first indication for IL-4 being important for human TAIM differentiation is that the percentage of TAIM-phenotype cells is decreased in chronic myeloid leukemia, and that this decrease can be partially restored after complete remission of chronic myeloid leukemia [104]. The gene discussed is IL4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.